blog

I'm a science communicator. AI is a bad writer, but a useful tool.

As a science communicator, I once feared that generative AI could threaten my career, but I’ve since learned to use it as a tool rather than a replacement.

Miriam Hyman | March 28, 2025

AI | Content Strategy | Writing

Is the Recent CRISPR “Doom-and-Gloom” Narrative Missing the Bigger Picture?

Once biotech's golden child, CRISPR now faces doubts from investors. Is this a downturn or a turning point for the CRISPR industry?

John Kang | March 20, 2025

Life Sciences | Current Affairs

Evolving Social Media Trends: Takeaways for Life Sciences Brands

Hootsuite's 2025 Social Media Trends report urges brands to balance creativity and credibility by embracing bold formats, short-form videos, and AI tools to deliver engaging yet trustworthy content.

Dillon Allie | March 10, 2025

Social Media | Digital Marketing

Elevating digital experiences: Pimcore and its addition to the Gartner Magic Quadrant

For the first time, the Gartner Magic Quadrant for Digital Experience Platforms has included Pimcore — a platform HDMZ has worked with for years. Find out more about Pimcore and what this inclusion means.

Craig Smith | February 20, 2025

Digital Solutions | Applications | Content Management System

NIH Budget Cuts: A Threat to Scientific Progress

Proposed cuts to the National Institutes of Health (NIH) budget—including a sharp reduction in indirect cost reimbursements—threaten to destabilize the very foundation of biomedical research in the United States.

Dillon Allie | February 13, 2025

Biotech | Life Sciences | Current Affairs

Trump, China’s Rise and The Forces Shaping Biotech’s Future

This year, the industry was rocked by the aftermath of UnitedHealthcare CEO Brian Thompson’s tragic murder last December, which led 11 major health insurance companies to quietly withdraw from JPM last week. Heightened security, bomb-sniffing dogs, and a palpable sense of caution surrounded Union Square. Thankfully, the conference, itself, concluded without incident.

John Kang | January 21, 2025

Conferences & Events | Biotech | Current Affairs

JPM 2025 Preview: Five Key Trends HDMZ Will Be Watching in Biotech

It’s the most wonderful time of the year for biotech and the broader life sciences industry — the J.P. Morgan (JPM) Healthcare Conference 2025 is just around the corner.

John Kang | January 06, 2025

Conferences & Events | Biotech